- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05887193
Effects of Contemporary Cycling Saddle Designs on Penile Transcutaneus Oxygen and Carbon Dioxide Levels in Elite Road Cyclists Riding on a Stationary Trainer (EC-SADDLE)
Study Overview
Status
Detailed Description
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
-
Prague, Czechia, 162 52
- Charles University
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Adult
Accepts Healthy Volunteers
Study Population
Description
Inclusion Criteria:
- gender: male, age: 18-45 years, discipline: road cycling, annual mileage: more than 14000 km (Tier 3-4)
Exclusion Criteria:
- Participants other than male, diagnosed with erectile dysfunction, acute or chronic back pain, acute (especially infectious) illness or injury, and in recovery from illness or injury are not eligible for inclusion in the research
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Basic Science
- Allocation: Randomized
- Interventional Model: Crossover Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Active Comparator: Group 1
Order of saddle testing: Joyseat saddle - Specialized Power saddle - Fizik Tundra M5 saddle
|
Biothesiometry using Biothesiometer (Bio Medical Instrument Co, Ohio, United States of America), placed on glans penis and second finger of nondominant hand.
Other Names:
Setting standardized posture of the rider on the bike using Retül technology (Retül, Specialized Bicycle Components Inc., Boulder, Colorado, United States of America)
Penile oxygen pressure using TCM5 Flex and tc84 electrode (Radiometer Medical ApS, Brønshøj, Denmark) placed on glans penis.
Riding a static bike Wahoo Bike (Wahoo Fitness LLC, Atlanta, Georgia, United States of America) for 3x 10 minutes in Zone 3 (Andy Coggan methodology) calculated from each individual subjects self reported Functional Threshold Power.
Measuring heart rate using Wahoo TICKR chest strap (Wahoo Fitness LLC, Atlanta, Georgia, United States of America)
Saddle pressure measurement, mean and max saddle pressure, saddle pressure distribution.
(Velometrik GmbH, Neukieritzsch, Germany).
|
|
Active Comparator: Group 2
Order of saddle testing: Joyseat saddle - Fizik Tundra M5 saddle - Specialized Power saddle
|
Biothesiometry using Biothesiometer (Bio Medical Instrument Co, Ohio, United States of America), placed on glans penis and second finger of nondominant hand.
Other Names:
Setting standardized posture of the rider on the bike using Retül technology (Retül, Specialized Bicycle Components Inc., Boulder, Colorado, United States of America)
Penile oxygen pressure using TCM5 Flex and tc84 electrode (Radiometer Medical ApS, Brønshøj, Denmark) placed on glans penis.
Riding a static bike Wahoo Bike (Wahoo Fitness LLC, Atlanta, Georgia, United States of America) for 3x 10 minutes in Zone 3 (Andy Coggan methodology) calculated from each individual subjects self reported Functional Threshold Power.
Measuring heart rate using Wahoo TICKR chest strap (Wahoo Fitness LLC, Atlanta, Georgia, United States of America)
Saddle pressure measurement, mean and max saddle pressure, saddle pressure distribution.
(Velometrik GmbH, Neukieritzsch, Germany).
|
|
Active Comparator: Group 3
Order of saddle testing: Specialized Power saddle - Fizik Tundra M5 saddle - Joyseat saddle
|
Biothesiometry using Biothesiometer (Bio Medical Instrument Co, Ohio, United States of America), placed on glans penis and second finger of nondominant hand.
Other Names:
Setting standardized posture of the rider on the bike using Retül technology (Retül, Specialized Bicycle Components Inc., Boulder, Colorado, United States of America)
Penile oxygen pressure using TCM5 Flex and tc84 electrode (Radiometer Medical ApS, Brønshøj, Denmark) placed on glans penis.
Riding a static bike Wahoo Bike (Wahoo Fitness LLC, Atlanta, Georgia, United States of America) for 3x 10 minutes in Zone 3 (Andy Coggan methodology) calculated from each individual subjects self reported Functional Threshold Power.
Measuring heart rate using Wahoo TICKR chest strap (Wahoo Fitness LLC, Atlanta, Georgia, United States of America)
Saddle pressure measurement, mean and max saddle pressure, saddle pressure distribution.
(Velometrik GmbH, Neukieritzsch, Germany).
|
|
Active Comparator: Group 4
Order of saddle testing: Specialized Power saddle - Joyseat saddle - Fizik Tundra M5 saddle
|
Biothesiometry using Biothesiometer (Bio Medical Instrument Co, Ohio, United States of America), placed on glans penis and second finger of nondominant hand.
Other Names:
Setting standardized posture of the rider on the bike using Retül technology (Retül, Specialized Bicycle Components Inc., Boulder, Colorado, United States of America)
Penile oxygen pressure using TCM5 Flex and tc84 electrode (Radiometer Medical ApS, Brønshøj, Denmark) placed on glans penis.
Riding a static bike Wahoo Bike (Wahoo Fitness LLC, Atlanta, Georgia, United States of America) for 3x 10 minutes in Zone 3 (Andy Coggan methodology) calculated from each individual subjects self reported Functional Threshold Power.
Measuring heart rate using Wahoo TICKR chest strap (Wahoo Fitness LLC, Atlanta, Georgia, United States of America)
Saddle pressure measurement, mean and max saddle pressure, saddle pressure distribution.
(Velometrik GmbH, Neukieritzsch, Germany).
|
|
Active Comparator: Group 5
Order of saddle testing: Fizik Tundra M5 saddle - Joyseat saddle - Specialized Power saddle
|
Biothesiometry using Biothesiometer (Bio Medical Instrument Co, Ohio, United States of America), placed on glans penis and second finger of nondominant hand.
Other Names:
Setting standardized posture of the rider on the bike using Retül technology (Retül, Specialized Bicycle Components Inc., Boulder, Colorado, United States of America)
Penile oxygen pressure using TCM5 Flex and tc84 electrode (Radiometer Medical ApS, Brønshøj, Denmark) placed on glans penis.
Riding a static bike Wahoo Bike (Wahoo Fitness LLC, Atlanta, Georgia, United States of America) for 3x 10 minutes in Zone 3 (Andy Coggan methodology) calculated from each individual subjects self reported Functional Threshold Power.
Measuring heart rate using Wahoo TICKR chest strap (Wahoo Fitness LLC, Atlanta, Georgia, United States of America)
Saddle pressure measurement, mean and max saddle pressure, saddle pressure distribution.
(Velometrik GmbH, Neukieritzsch, Germany).
|
|
Active Comparator: Group 6
Order of saddle testing: Fizik Tundra M5 saddle - Specialized Power saddle - Joyseat saddle
|
Biothesiometry using Biothesiometer (Bio Medical Instrument Co, Ohio, United States of America), placed on glans penis and second finger of nondominant hand.
Other Names:
Setting standardized posture of the rider on the bike using Retül technology (Retül, Specialized Bicycle Components Inc., Boulder, Colorado, United States of America)
Penile oxygen pressure using TCM5 Flex and tc84 electrode (Radiometer Medical ApS, Brønshøj, Denmark) placed on glans penis.
Riding a static bike Wahoo Bike (Wahoo Fitness LLC, Atlanta, Georgia, United States of America) for 3x 10 minutes in Zone 3 (Andy Coggan methodology) calculated from each individual subjects self reported Functional Threshold Power.
Measuring heart rate using Wahoo TICKR chest strap (Wahoo Fitness LLC, Atlanta, Georgia, United States of America)
Saddle pressure measurement, mean and max saddle pressure, saddle pressure distribution.
(Velometrik GmbH, Neukieritzsch, Germany).
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
pO2_change_point
Time Frame: During a single laboratory visit consisting of three 10-minute cycling intervals with three 5-minute pause time in between cycling intervals (total assessment time approximately 45 minutes).
|
Parameter pO2_change_point is the time from start of TcPO₂ measurement to the identified change point, determined within the 50-400 s interval as the transition between the fitted initial linear trend and the subsequent linear trend in TcPO₂
|
During a single laboratory visit consisting of three 10-minute cycling intervals with three 5-minute pause time in between cycling intervals (total assessment time approximately 45 minutes).
|
|
pCO2_change_point
Time Frame: During a single laboratory visit consisting of three 10-minute cycling intervals with three 5-minute pause time in between cycling intervals (total assessment time approximately 45 minutes).
|
Parameter pCO2_change_point is the time from start of TcPCO₂ measurement to the identified change point, determined within the 200-550 s interval as the transition between the fitted initial linear trend and the subsequent linear trend in TcPCO₂
|
During a single laboratory visit consisting of three 10-minute cycling intervals with three 5-minute pause time in between cycling intervals (total assessment time approximately 45 minutes).
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
pO2_start
Time Frame: During a single laboratory visit consisting of three 10-minute cycling intervals with three 5-minute pause time in between cycling intervals (total assessment time approximately 45 minutes).
|
The value of the fitted trend at time 0 in TcPO₂ measurement.
|
During a single laboratory visit consisting of three 10-minute cycling intervals with three 5-minute pause time in between cycling intervals (total assessment time approximately 45 minutes).
|
|
pO2_decline
Time Frame: During a single laboratory visit consisting of three 10-minute cycling intervals with three 5-minute pause time in between cycling intervals (total assessment time approximately 45 minutes).
|
The slope of the fitted trend of decline in TcPO₂ after initial 20s.
|
During a single laboratory visit consisting of three 10-minute cycling intervals with three 5-minute pause time in between cycling intervals (total assessment time approximately 45 minutes).
|
|
pO2_end
Time Frame: During a single laboratory visit consisting of three 10-minute cycling intervals with three 5-minute pause time in between cycling intervals (total assessment time approximately 45 minutes).
|
The slope of the second fitted trend after pO2_change_point in TcPO₂ measurement.
|
During a single laboratory visit consisting of three 10-minute cycling intervals with three 5-minute pause time in between cycling intervals (total assessment time approximately 45 minutes).
|
|
pO2_part1
Time Frame: During a single laboratory visit consisting of three 10-minute cycling intervals with three 5-minute pause time in between cycling intervals (total assessment time approximately 45 minutes).
|
The average value of TcPO₂ measurements in the first 20 s segment.
|
During a single laboratory visit consisting of three 10-minute cycling intervals with three 5-minute pause time in between cycling intervals (total assessment time approximately 45 minutes).
|
|
pO2_part2
Time Frame: During a single laboratory visit consisting of three 10-minute cycling intervals with three 5-minute pause time in between cycling intervals (total assessment time approximately 45 minutes).
|
The average value of TcPO₂ measurements for the second segment, from 21 s to the trend pO2_change_point.
|
During a single laboratory visit consisting of three 10-minute cycling intervals with three 5-minute pause time in between cycling intervals (total assessment time approximately 45 minutes).
|
|
pO2_part3
Time Frame: During a single laboratory visit consisting of three 10-minute cycling intervals with three 5-minute pause time in between cycling intervals (total assessment time approximately 45 minutes).
|
The average value of TcPO₂ measurements for the third segment after pO2_change_point.
|
During a single laboratory visit consisting of three 10-minute cycling intervals with three 5-minute pause time in between cycling intervals (total assessment time approximately 45 minutes).
|
|
pO2_mean
Time Frame: During a single laboratory visit consisting of three 10-minute cycling intervals with three 5-minute pause time in between cycling intervals (total assessment time approximately 45 minutes).
|
The average of all TcPO₂ measurements in one interval.
|
During a single laboratory visit consisting of three 10-minute cycling intervals with three 5-minute pause time in between cycling intervals (total assessment time approximately 45 minutes).
|
|
pO2_median
Time Frame: During a single laboratory visit consisting of three 10-minute cycling intervals with three 5-minute pause time in between cycling intervals (total assessment time approximately 45 minutes).
|
The median of all TcPO₂ measurements in one interval.
|
During a single laboratory visit consisting of three 10-minute cycling intervals with three 5-minute pause time in between cycling intervals (total assessment time approximately 45 minutes).
|
|
pCO2_start
Time Frame: During a single laboratory visit consisting of three 10-minute cycling intervals with three 5-minute pause time in between cycling intervals (total assessment time approximately 45 minutes).
|
The value of the fitted trend at time 0 in TcPCO₂ measurement.
|
During a single laboratory visit consisting of three 10-minute cycling intervals with three 5-minute pause time in between cycling intervals (total assessment time approximately 45 minutes).
|
|
pCO2_incline
Time Frame: During a single laboratory visit consisting of three 10-minute cycling intervals with three 5-minute pause time in between cycling intervals (total assessment time approximately 45 minutes).
|
The slope of the fitted trend of increase in TcPCO₂ in the first segment before pCO2_change_point
|
During a single laboratory visit consisting of three 10-minute cycling intervals with three 5-minute pause time in between cycling intervals (total assessment time approximately 45 minutes).
|
|
pCO2_end
Time Frame: During a single laboratory visit consisting of three 10-minute cycling intervals with three 5-minute pause time in between cycling intervals (total assessment time approximately 45 minutes).
|
The slope of the fitted trend in TcPCO₂ in the second segment after pCO2_change_point.
|
During a single laboratory visit consisting of three 10-minute cycling intervals with three 5-minute pause time in between cycling intervals (total assessment time approximately 45 minutes).
|
|
pCO2_part1
Time Frame: During a single laboratory visit consisting of three 10-minute cycling intervals with three 5-minute pause time in between cycling intervals (total assessment time approximately 45 minutes).
|
The average value of TcPCO₂ measurements in the first segment before pCO2_change_point.
|
During a single laboratory visit consisting of three 10-minute cycling intervals with three 5-minute pause time in between cycling intervals (total assessment time approximately 45 minutes).
|
|
pCO2_part2
Time Frame: During a single laboratory visit consisting of three 10-minute cycling intervals with three 5-minute pause time in between cycling intervals (total assessment time approximately 45 minutes).
|
The average value of TcPCO₂ measurements in the second segment after pCO2_change_point.
|
During a single laboratory visit consisting of three 10-minute cycling intervals with three 5-minute pause time in between cycling intervals (total assessment time approximately 45 minutes).
|
|
pCO2_mean
Time Frame: During a single laboratory visit consisting of three 10-minute cycling intervals with three 5-minute pause time in between cycling intervals (total assessment time approximately 45 minutes).
|
The average of all TcPCO₂ measurements in one interval.
|
During a single laboratory visit consisting of three 10-minute cycling intervals with three 5-minute pause time in between cycling intervals (total assessment time approximately 45 minutes).
|
|
pCO2_median
Time Frame: During a single laboratory visit consisting of three 10-minute cycling intervals with three 5-minute pause time in between cycling intervals (total assessment time approximately 45 minutes).
|
The median of all TcPCO₂ measurements in one interval.
|
During a single laboratory visit consisting of three 10-minute cycling intervals with three 5-minute pause time in between cycling intervals (total assessment time approximately 45 minutes).
|
|
logratio_11_8
Time Frame: During a single laboratory visit consisting of three 10-minute cycling intervals with three 5-minute pause time in between cycling intervals (total assessment time approximately 45 minutes).
|
The logarithmic value of the ratio of the load on the front and rear parts of the saddle, where the saddle is divided in a ratio of 11:8 longitudinally.
|
During a single laboratory visit consisting of three 10-minute cycling intervals with three 5-minute pause time in between cycling intervals (total assessment time approximately 45 minutes).
|
|
PERI
Time Frame: During a single laboratory visit consisting of three 10-minute cycling intervals with three 5-minute pause time in between cycling intervals (total assessment time approximately 45 minutes).
|
Pressure value in the predefined perineal area with an area of 44 cm² in front of the ischial tuberosity maxima.
|
During a single laboratory visit consisting of three 10-minute cycling intervals with three 5-minute pause time in between cycling intervals (total assessment time approximately 45 minutes).
|
|
modPSRG/F
Time Frame: A baseline testing at the beginning of the testing protocol lasting around 5 minutes.
|
Vibrotactile thresholds were measured at the volar distal phalanx of the non-dominant hand and midline of the glans penis.
The probe was placed perpendicular without additional pressure.
Voltage was gradually increased until the first sensation was reported, then increased further and slowly decreased until sensation was lost.
Upper and lower thresholds were recorded three times per site, averaged, and used to calculate the modified Penile Sensitivity Ratio Glans/Finger via the following formula.
Average of the three glans upper+lower threshold values divided by the average of the three finger upper+lower threshold values.
|
A baseline testing at the beginning of the testing protocol lasting around 5 minutes.
|
|
CVdrift
Time Frame: During a single laboratory visit consisting of three 10-minute cycling intervals with three 5-minute pause time in between cycling intervals (total assessment time approximately 45 minutes).
|
The percentage of cardiovascular drift calculated as a ratio between average Power and average Heart Rate between the first and second part of the 10-minute interval. ((P1/HR1) - (P2/HR2))/(P1/HR1) * 100 where: P1 - Average Power from first half part of the workout P2 - Average Power from second half part of the workout HR1 - Average Heart Rate from first half part of the workout HR2 - Average Heart Rate from second half part of the workout |
During a single laboratory visit consisting of three 10-minute cycling intervals with three 5-minute pause time in between cycling intervals (total assessment time approximately 45 minutes).
|
|
Bike Fit parameters
Time Frame: During a single laboratory visit consisting of three 10-minute cycling intervals with three 5-minute pause time in between cycling intervals (total assessment time approximately 45 minutes).
|
Bike Fit values as recorded by Retül V7 System. KOPS - Knee Over Pedal Spindle - The fore/aft offset of the knee marker relative to the pedal spindle at 3 o'clock in the pedal stroke (90° in the downstroke) MKF - Maximum Knee Flexion - Maximum flexion of the knee joint at any point in the pedal stroke defined by the line connecting hip and knee markers and the line connecting knee and ankle markers MKE - Maximum Knee Extension - Maximum extension of the knee joint at any point in the pedal stroke defined by the line connecting hip and knee markers and the line connecting knee and ankle markers SAW - Shoulder Angle to Wrist - The angle of the shoulder joint defined as the angle at intersection of the line connecting hip and shoulder markers, and the line connecting wrist and shoulder markers BA - Back Angle - The angle of the back relative to the horizon defined by the hip and shoulder marker |
During a single laboratory visit consisting of three 10-minute cycling intervals with three 5-minute pause time in between cycling intervals (total assessment time approximately 45 minutes).
|
|
pO2_start
Time Frame: During a single laboratory visit consisting of three 10-minute cycling intervals with three 5-minute pause time in between cycling intervals (total assessment time approximately 45 minutes).
|
Mean of first 12s of TcPO₂ measurements in each 10 minute interval.
|
During a single laboratory visit consisting of three 10-minute cycling intervals with three 5-minute pause time in between cycling intervals (total assessment time approximately 45 minutes).
|
|
pO2_end
Time Frame: During a single laboratory visit consisting of three 10-minute cycling intervals with three 5-minute pause time in between cycling intervals (total assessment time approximately 45 minutes).
|
Mean of last 12s of TcPO₂ measurements in each 10 minute interval.
|
During a single laboratory visit consisting of three 10-minute cycling intervals with three 5-minute pause time in between cycling intervals (total assessment time approximately 45 minutes).
|
|
pCO2_start
Time Frame: During a single laboratory visit consisting of three 10-minute cycling intervals with three 5-minute pause time in between cycling intervals (total assessment time approximately 45 minutes).
|
Mean of first 12s of TcPCO₂ measurements in each 10 minute interval.
|
During a single laboratory visit consisting of three 10-minute cycling intervals with three 5-minute pause time in between cycling intervals (total assessment time approximately 45 minutes).
|
|
pCO2_end
Time Frame: During a single laboratory visit consisting of three 10-minute cycling intervals with three 5-minute pause time in between cycling intervals (total assessment time approximately 45 minutes).
|
Mean of last 12s of TcPCO₂ measurements in each 10 minute interval.
|
During a single laboratory visit consisting of three 10-minute cycling intervals with three 5-minute pause time in between cycling intervals (total assessment time approximately 45 minutes).
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: Milan Martínek, Mgr., Ph.D., Charles University, Czech Republic
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
- Urogenital Diseases
- Genital Diseases
- Neurologic Manifestations
- Nervous System Diseases
- Mental Disorders
- Genital Diseases, Male
- Male Urogenital Diseases
- Sensation Disorders
- Sexual Dysfunction, Physiological
- Sexual Dysfunctions, Psychological
- Somatosensory Disorders
- Pathological Conditions, Signs and Symptoms
- Signs and Symptoms
- Erectile Dysfunction
- Hypesthesia
- Investigative Techniques
- Clinical Laboratory Techniques
- Diagnostic Techniques and Procedures
- Diagnosis
- Diagnostic Techniques, Respiratory System
- Diagnostic Techniques, Cardiovascular
- Physical Examination
- Heart Function Tests
- Respiratory Function Tests
- Blood Chemical Analysis
- Clinical Chemistry Tests
- Blood Gas Analysis
- Oximetry
- Blood Gas Monitoring, Transcutaneous
- Heart Rate Determination
Other Study ID Numbers
- CharlesUCR - EC-SADDLE
- UK FTVS 002/2023 (Other Identifier: aculty of Physical Education and Sport, Charles University, Ethics Committee)
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.